The FDA has approved AstraZeneca's treatment for use outside of healthcare facilities, but it will still require a prescription.
On Friday, the FDA approved the at-home use of FluMist, allowing those who are hesitant about needles to access a potentially lifesaving nasal spray flu vaccine more easily.
This marks the first time parents can administer the vaccine to children, and adults can use it themselves outside of a healthcare facility, although a prescription will still be necessary. FluMist is expected to be available from online pharmacies by next fall.
AstraZeneca, the producer, plans to launch a FluMist Home website where users can complete a questionnaire reviewed by a pharmacist before the treatment is shipped directly to them. The nasal spray will also remain available for in-office use. The current cost for a dose is approximately $35 to $45, depending on insurance coverage.
Dr. Peter Marks, director of the FDA’s vaccine center, emphasized that this approval offers a convenient option for families to receive a safe and effective flu vaccine. The FDA required AstraZeneca to demonstrate that the instructions for at-home use were clear and feasible, concluding that they were, but recommending that caregivers administer the spray to children aged 2 to 17.
Dr. Abraar Karan, an infectious disease specialist, noted that logistical barriers often prevent people from getting vaccinated, including the need for appointments and recovery time. He believes that the new at-home option will reduce these barriers and encourage more people to get vaccinated before flu season begins.
Read next
05:40
Iran has rejected a U.S. demand to halt uranium enrichment ahead of a new round of nuclear talks set for Saturday in Oman. U.S. Secretary of State Marco Rubio said Iran must stop all enrichment and import only low-level uranium for civilian use.
16:50
Ceasefire
U.S. Vice President JD Vance has delivered a stark ultimatum to Moscow and Kyiv, urging them to accept a proposed ceasefire deal or face a withdrawal of American diplomatic efforts.
23:55
U.S. President Donald Trump's envoy, Steve Witkoff, is traveling to Moscow this week for renewed peace talks with Russian President Vladimir Putin. The White House confirmed Tuesday that Witkoff will attempt to advance negotiations aimed at ending the war in Ukraine.
12:30
South Korea, US
South Korean Finance Minister Choi Sang-mok departed for Washington on Tuesday to lead high-level trade negotiations with U.S. officials.
06:24
China’s pivot away from U.S. liquefied petroleum gas under new tariffs is shaking global energy flows, slashing demand, and fuelling a scramble for alternatives across Asia, with Middle Eastern suppliers and rival buyers seizing the moment.
What is your opinion on this topic?
Leave the first comment